Sensei Biotherapeutics is developing an innovative pipeline of first-in-class immune activating agents for a broad array of cancers including solid tumors and hematological malignancies. Our therapies benefit from a precision medicine approach that has the potential to identify patients that will benefit most from our therapies.

Education

Biotechnology

Sensei Bio

Sensei Bio's headquarters in Gaithersburg, MD, United States

John K. Celebi

Edward Van Der Horst

Humberto Moran

Stephanie Krebs

Christopher Gerry

Erin Colgan

Sara Pai

Robert Schreiber

Alain Algazi

Daniel H. Sterman

Samuel Broder

Bob Holmen

James Peyer

Tom Ricks

Maura Gillison

William Ringo

Dan Sterman

Kristian Humer

Richard Ulevitch

The Corporate Governance team at Sensei Bio ensures adherence to regulatory standards, ethical practices, and best governance principles across the organization. They provide strategic oversight and guidance to the Board while facilitating effective communication between management and stakeholders. This team's efforts help maintain transparency, accountability, and strategic alignment with the company's mission to advance innovative cancer therapies.

Corporate Governance

The Research and Development team at Sensei Bio is dedicated to pioneering and advancing innovative immune therapies for cancer treatment. This multidisciplinary team collaborates on drug discovery, preclinical development, and clinical operations, utilizing a precision medicine approach to identify and optimize therapies that target specific patient populations. Their efforts are focused on translating scientific insights into effective treatment options for patients with various malignancies.

Research and Development

The Advisory Team at Sensei Bio provides strategic guidance and expertise in the development of immune activating agents for cancer therapies. Comprising a group of experienced advisors, the team collaborates to refine research directions, enhance clinical trial designs, and ensure that the company’s precision medicine approach effectively targets patients most likely to benefit from the innovative treatments. Their insights help drive the pipeline forward and optimize the therapeutic impact of Sensei Bio's offerings.

Advisory Team

The Leadership Team at Sensei Bio is responsible for setting the strategic direction of the company, overseeing its financial and operational performance, and ensuring the successful development and commercialization of innovative cancer therapies. This team collaborates closely to drive advancements in precision medicine while fostering a culture of innovation and accountability within the organization.

Leadership Team

The Legal and Compliance team at Sensei Bio ensures that the company adheres to all regulatory requirements and legal standards related to the development of its innovative cancer therapies. This team provides guidance on intellectual property, contracts, and compliance matters, while also collaborating with other departments to navigate the complexities of biopharmaceutical regulations and support the strategic goals of the organization.

Legal and Compliance

The Finance and Accounting team at Sensei Bio is responsible for managing the company's financial health and ensuring accurate financial reporting. This team oversees budgeting, forecasting, and financial analysis to support strategic decision-making, while also ensuring compliance with accounting standards and regulations. By providing financial insights and maintaining robust accounting practices, they play a crucial role in facilitating the development of innovative cancer therapies.

Sensei Bio

Org chart

Board & advisors

Teams

Corporate Governance

Research and Development

Advisory Team

Leadership Team

Legal and Compliance

Finance and Accounting

Offices

Sensei Bio

Org chart

Board & advisors

Teams

Corporate Governance

Research and Development

Advisory Team

Leadership Team

Legal and Compliance

Finance and Accounting

Offices

Related companies